Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease

PURPOSE: Characterize the safety and tolerability of lifitegrast ophthalmic solution 5.0% for the treatment of dry eye disease. METHODS: Pooled data from five randomized controlled trials were analyzed. Key inclusion criteria were adults with dry eye disease (Schirmer tear test score ⩾1 and ⩽10 mm,...

Descripción completa

Detalles Bibliográficos
Autores principales: Nichols, Kelly K, Donnenfeld, Eric D, Karpecki, Paul M, Hovanesian, John A, Raychaudhuri, Aparna, Shojaei, Amir, Zhang, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625033/
https://www.ncbi.nlm.nih.gov/pubmed/30112930
http://dx.doi.org/10.1177/1120672118791936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625033/
https://www.ncbi.nlm.nih.gov/pubmed/30112930
http://dx.doi.org/10.1177/1120672118791936

Ejemplares similares